Check out these tips for orthopedic drug reimbursement

Why This Topic Matters

Orthopedic practices frequently bill for injectable drugs and related services, and reimbursement can depend on documentation quality, claim formatting, and correct reporting of supply and diagnosis information. The article helps revenue-cycle and coding staff understand the kinds of issues that can affect payment and denial rates for these claims.

Article Sections

1. Unlisted drug claims and documentation tips

   General guidance on handling office-administered drugs that may not yet have established reporting options. The section focuses on claims processing, supporting documentation, and payer submission concerns.

2. Reporting orthopedic injections and related drug supply

   A brief example of how a common orthopedic office service is reported alongside drug supply and diagnosis information. The section identifies the broad service categories involved without providing coding instructions.

3. Medicare utilization and denial trends for orthopedic drugs

   A summary of claims-data trends for orthopedic drug reimbursement, including overall payment growth, denial growth, and the most commonly billed drugs in the period discussed.